Canopy Growth (CGC) Inventory (2017 - 2026)
Canopy Growth (CGC) reported Inventory of $80.6 million for Q1 2026, up 19.99% on a YoY basis from $67.2 million in Q1 2025, and up 6.47% sequentially from $75.7 million in Q4 2025.
Canopy Growth (CGC) Inventory (2017 - 2026) Analysis & Trends
Canopy Growth (CGC) has 10 years of Inventory data on file, last reported at $80.6 million in Q1 2026.
- For the quarter ending Q1 2026, Inventory rose 19.99% year-over-year to $80.6 million; the trailing twelve-month figure through Mar 2026 stood at $80.6 million (up 19.99% YoY), and the FY2026 full-year result was $80.6 million, up 19.99% from the prior year.
- Inventory climbed to $80.6 million in Q1 2026, from $75.7 million in the prior quarter.
- In the past five years, Inventory ranged from a high of $162.4 million in Q3 2022 to a low of $57.4 million in Q1 2024.
- A 5-year average of $91.5 million and a median of $67.7 million in 2025 frame the typical range for Inventory.
- Across the five-year window, Inventory sank 61.87% in 2023 and grew 19.99% in 2026, its largest moves.
- Tracing CGC's Inventory over 5 years: stood at $157.7 million in 2022, then sank by 59.51% to $63.8 million in 2023, then increased by 1.76% to $65.0 million in 2024, then advanced by 16.51% to $75.7 million in 2025, then gained by 6.47% to $80.6 million in 2026.
- Business Quant data shows CGC's Inventory at $80.6 million in Q1 2026, $75.7 million in Q4 2025, and $74.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 1.36 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.18 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 2.55 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 8.91 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 178.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 2.49 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 3.93 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 64.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1.72 Bn |
| 10 | Canopy Growth | 197.77 Mn | -68.15 Mn | - | 80.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 80.59 Mn |
| Dec 31, 2025 | 75.69 Mn |
| Sep 30, 2025 | 74.39 Mn |
| Jun 30, 2025 | 67.71 Mn |
| Mar 31, 2025 | 67.16 Mn |
| Dec 31, 2024 | 64.97 Mn |
| Sep 30, 2024 | 66.04 Mn |
| Jun 30, 2024 | 61.79 Mn |
| Mar 31, 2024 | 57.36 Mn |
| Dec 31, 2023 | 63.84 Mn |
| Sep 30, 2023 | 65.25 Mn |
| Jun 30, 2023 | 105.76 Mn |
| Mar 31, 2023 | 61.56 Mn |
| Dec 31, 2022 | 157.69 Mn |
| Sep 30, 2022 | 162.36 Mn |
| Jun 30, 2022 | 161.21 Mn |
| Mar 31, 2022 | 161.48 Mn |
| Dec 31, 2021 | 290.16 Mn |
| Sep 30, 2021 | 280.67 Mn |
| Jun 30, 2021 | 334.91 Mn |